文献速递关节外科

脂质体布比卡因膝关节周围注射与连续股神经阻滞在全膝关节置换术后疼痛管理中的比较:一项随机对照试验

Periarticular Knee Injection With Liposomal Bupivacaine and Continuous Femoral Nerve Block for Postoperative Pain Management After Total Knee Arthroplasty: A Randomized Controlled Trial.
PubMed 文献 · J Arthroplasty · 2018-11-23

65例初次单侧全膝关节置换患者随机分为连续股神经阻滞(CFNB)联合布比卡因膝关节周围注射组或布比卡因-脂质体布比卡因混合膝关节周围注射组。主要结局为术后24小时最大屈膝时疼痛强度,CFNB组低于LB组。LB组72小时内平均峰值血清布比卡因浓度低于CFNB组。

要点

  • 术后24小时最大屈膝时疼痛评分CFNB组7.91(95%CI 7.19-8.61)低于LB组8.95(95%CI 8.42-9.48),P=0.02。
  • LB组72小时内平均峰值血清布比卡因浓度为0.55 μg/mL,低于CFNB组的1.4 μg/mL(P=0.0008)。
  • CFNB组有1例患者超过已报道的血清布比卡因毒性最低阈值。

核心结论

  • 手术当天两组疼痛控制相似,但CFNB组在术后24小时最大屈膝时疼痛强度更低。
  • LB组研究期间总血清布比卡因浓度保持在毒性阈值以下。

研究设计与样本

  • 随机对照试验,纳入65例接受初次单侧全膝关节置换的患者,随机分为CFNB联合布比卡因PAI组(CFNB组)或布比卡因-脂质体布比卡因混合PAI组(LB组)。

主要发现

  • CFNB组术后24小时最大屈膝时疼痛评分为7.91(95%CI 7.19-8.61),LB组为8.95(95%CI 8.42-9.48),P=0.02。
  • LB组72小时内平均峰值血清布比卡因浓度为0.55 μg/mL,CFNB组为1.4 μg/mL(P=0.0008)。
  • CFNB组有1例患者超过已报道的血清布比卡因毒性最低阈值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Local periarticular infiltration (PAI) analgesia has emerged as an important component of multimodal approaches to treat total knee arthroplasty postoperative pain. Liposomal bupivacaine may provide prolonged analgesic duration when injected into the surrounding tissues. The purpose of this study was to compare the analgesic efficacy and serum bupivacaine levels of a continuous femoral nerve block (CFNB) with bupivacaine to PAI with liposomal bupivacaine. METHODS: Sixty-five patients undergoing primary unilateral total knee arthroplasty were randomized into 2 groups: (1) CFNB and PAI with bupivacaine (CFNB group) or (2) PAI with bupivacaine:liposomal bupivacaine mixture at the end of surgery (LB group). The primary outcome was pain intensity at maximum knee flexion 24 hours following surgery. Secondary outcomes included pain intensities at rest and movement at timed intervals and serum bupivacaine levels. RESULTS: Patients in the CFNB group experienced lower pain scores at maximum knee flexion at 24 hours (7.91; 95% confidence interval, 7.19-8.61) compared to the LB group (8.95; 95% confidence interval, 8.42-9.48; P = .02). The mean peak serum bupivacaine level in the LB group up to 72 hours was 0.55 μg/mL versus 1.4 μg/mL for CFNB group (P = .0008) with one patient in the CFNB group exceeding the reported minimum serum bupivacaine threshold for toxicity. CONCLUSION: While similar pain control was observed on the day of surgery for both groups, patients with a CFNB experienced lower pain intensities during maximum knee flexion at 24 hours. Total serum concentrations in LB group remained below the toxicity threshold over the study period.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Marino J, Scuderi G, Dowling O, et al. Periarticular Knee Injection With Liposomal Bupivacaine and Continuous Femoral Nerve Block for Postoperative Pain Management After Total Knee Arthroplasty: A Randomized Controlled Trial. J Arthroplasty. 2018. PMID: 30583813. doi:10.1016/j.arth.2018.11.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。